Medicines May Soon Come with Braille Labels, Audio QR Codes

New Delhi: India’s drug regulatory authority is considering having braille cards and voice-assisted QR codes on medicine strips to make them patient friendly. The regulatory body has invited public comments for further action.

Earlier, the regulatory body had received representations regarding problems being faced by blind or visually impaired people to read medicines, tablet/capsule strips.

“These special peoples face difficulty to know the name and expiry of the medicines and depend on others therefore, it was requested that a provision under Drugs and Cosmetics Act and Rules to label the drugs with braille inscriptions be inserted,” people in the know told ET.

The matter was then deliberated by the Drugs Consultative Committee (DCC) meeting in 2020 which recommended constituting a sub- committee to examine the issue in detail for further consideration.

The sub-committee which was constituted on DCC’s recommendation had submitted its report, recommending support in the ease of access of medication to the visually impaired persons, the guideline regarding additional labelling in braille language was proposed to be implemented “initially on voluntary basis” for the drugs, which are supplied in mono carton pack size.

It was also recommended that consideration should be given to medicinal products likely to be used by a high visually impaired target population, e.g. certain eye drop preparations.

It was also advised that the braille labels would not be applicable for the products dispensed or given under supervision of health care professional’s e.g. injectable, vaccine etc.

Related Posts

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs